Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Puma Biotechnology (PBYI) Other Non Operating Income (2017 - 2025)

Puma Biotechnology (PBYI) has disclosed Other Non Operating Income for 9 consecutive years, with $143000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income fell 46.64% year-over-year to $143000.0, compared with a TTM value of $1.0 million through Dec 2025, up 19.14%, and an annual FY2025 reading of $1.0 million, up 19.14% over the prior year.
  • Other Non Operating Income was $143000.0 for Q4 2025 at Puma Biotechnology, up from $115000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $22.5 million in Q4 2021 and bottomed at -$204000.0 in Q4 2022.
  • Average Other Non Operating Income over 5 years is $1.3 million, with a median of $88500.0 recorded in 2023.
  • The sharpest move saw Other Non Operating Income skyrocketed 32531.88% in 2021, then crashed 184.0% in 2023.
  • Year by year, Other Non Operating Income stood at $22.5 million in 2021, then crashed by 100.91% to -$204000.0 in 2022, then soared by 414.22% to $641000.0 in 2023, then crashed by 58.19% to $268000.0 in 2024, then plummeted by 46.64% to $143000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for PBYI at $143000.0 in Q4 2025, $115000.0 in Q3 2025, and $410000.0 in Q2 2025.